Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure
Authors:
- 18 April 2022
- journal article
- research article
- Published by Elsevier in Clinical Immunology
- Vol. 238, 109016
Abstract
No abstract availableKeywords
All Related Versions
This publication has 58 references indexed in Scilit:
- MiR155‐5p in adventitial fibroblasts‐derived extracellular vesicles inhibits vascular smooth muscle cell proliferation via suppressing angiotensin‐converting enzyme expressionJournal of Extracellular Vesicles, 2019
- NETopathies? Unraveling the Dark Side of Old Diseases through NeutrophilsFrontiers in Immunology, 2017
- Granulocyte colony-stimulating factor (G-CSF) increases histone-complexed DNA plasma levels in healthy volunteersClinical and Experimental Medicine, 2016
- Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the diseaseAnnals of the Rheumatic Diseases, 2014
- IL-6 in Inflammation, Immunity, and DiseaseCold Spring Harbor Perspectives in Biology, 2014
- Introducing the Palliative Performance Scale to clinicians: the Grampian experienceBMJ Supportive & Palliative Care, 2012
- Tissue factor–thrombin signaling enhances the fibrotic activity of myofibroblasts in systemic sclerosis through up‐regulation of endothelin receptor AArthritis & Rheumatism, 2011
- The multivalent activity of the tissue factor–thrombin pathway in thrombotic and non-thrombotic disorders as a target for therapeutic interventionExpert Opinion on Therapeutic Targets, 2010
- Extracellular DNA traps promote thrombosisProceedings of the National Academy of Sciences, 2010
- Direct Thrombin Inhibition Reduces Lung Collagen, Accumulation, and Connective Tissue Growth Factor mRNA Levels in Bleomycin-Induced Pulmonary FibrosisThe American Journal of Pathology, 2001